Pfizer is being sued for excluding whites and Asians from its prestigious “Breakthrough Fellowship,” a nine-year program that includes a fully funded master’s degree and guaranteed employment with the pharmaceutical giant.

The lawsuit, filed on Thursday by the medical advocacy group Do No Harm, says that the program’s exclusionary criteria violate five different civil rights laws: the Civil Rights Act of 1866, which bans racial discrimination in contracting; New York City and New York State’s human rights laws, which ban race discrimination in internships, training programs, and employment; Title VI of the 1964 Civil Rights Act, which bans race discrimination in federally funded entities; and Section 1557 of the Affordable Care Act, which bans race discrimination in federally funded health care programs.

Read more on the Washington Free Beacon.

Everyone involved in health care can agree on two truths: First, many minority populations have unequal access to care. Second, as a result, they often have disparate health outcomes.

Yet acknowledging these truths does not lead to LaShyra Nolen’s conclusion that health care must be “antiracist” (“Woke medicine doesn’t mean worse medicine,” Ideas, Sept. 11). In practice, what Nolen calls for could lead to health care that deliberately discriminates on the basis of race — a false cure.

To see what antiracism means, consider the antiracist pilot program that two Harvard Medical School professors announced last year at Boston’s Brigham and Women’s Hospital. They pledged to provide a “preferential admission option” for certain minority patients, requiring overt discrimination by skin color. Writ large, antiracism would embed this divisive and dangerous practice across all of health care. Patients could be denied or delayed treatment, not because of their medical needs, but because of their race.

By all means, let’s break down barriers that prevent many minorities from accessing care. But let’s not push the life-saving institution of health care toward racial discrimination of any kind and the resulting damage it could entail.

Dr. Stanley Goldfarb
Bryn Mawr, Pa.

The writer is chairman of the advocacy group Do No Harm and former associate dean of the Perelman School of Medicine at the University of Pennsylvania.

A national association of medical professionals has filed a lawsuit against pharmaceutical giant Pfizer , alleging that the company runs a fellowship that illegally excludes white and Asian American applicants.

Do No Harm claimed that Pfizer’s Breakthrough Fellowship Program violates several state and federal laws as it is racially discriminatory and requires that applicants meet its stated aim of “increasing the pipeline for Black/African American, Latino/Hispanic and Native Americans.”

Read more on the Washington Examiner.

Do No Harm, a nonprofit whose mission is to “protect health care from a radical, divisive, and discriminatory ideology,” recently sued Pfizer, arguing that the pharmaceutical giant’s “Breakthrough Fellowship Program” illegally discriminates by race.

Pfizer describes the fellowship on its website as “a nine-year commitment to increase minority representation at Pfizer, designed to enhance our pipeline of diverse leaders.” The program “works to advance students and early career colleagues of Black/African American, Latino/Hispanic and Native American descent with a goal of developing 100 fellows by 2025.”

Read more on National Review.

A health care advocacy group has filed a federal lawsuit against the journal Health Affairs, alleging it violated the Civil Rights Act by excluding White candidates from a racial equity fellowship.

Do No Harm filed the lawsuit last week in the U.S. District Court for the District of Columbia. It alleges that the monthly journal’s Health Equity Fellowship for Trainees defies the law’s color-blind definition of racial discrimination under Title VI because publisher Project HOPE accepts government funding.

Read more on the Washington Times.

A prestigious health journal offers a fellowship that appears to bar white applicants from joining, according to a complaint against the program filed in a U.S. District Court and obtained by the Daily Caller.

Health Affairs is currently accepting applications for its “Health Equity Fellowship,” which requires that applicants identify as “American Indian/Alaskan Native, African American/Black, Asian American, Native Hawaiian and other Pacific Islander, and Hispanic/Latino.” Applicants must also be researching topics that advance “racial health equity among historically marginalized populations.”

The program is designed to “advance racial equity in health policy and health services scholarly publishing.”

Read more on the Daily Caller.

EXCLUSIVE — Nonprofit organization Do No Harm filed a lawsuit on Tuesday against Health Affairs and Project Hope, claiming a fellowship for minorities is illegal because of “blatant discrimination” against White applicants. 

The complaint, filed in U.S. District Court for the District of Columbia, alleges that Health Affairs, a prominent health policy journal and its parent company Project Hope are “running a race-segregated health journal fellowship” called Health Equity Fellowship for Trainees. 

Do No Harm chairman Dr. Stanley Goldfarb said his organization is “opposed to discrimination in all of its manifestations,” including a fellowship program solely for non-White applicants.

“To propose a fellowship program whose key requirement is skin color is blatant discrimination. If the goal is to promote students with less opportunity, then promote such students without racial stipulations. We have civil rights laws in this nation to prevent this sort of racialism and this lawsuit helps promote those laws,” Dr. Goldfarb told Fox News Digital. 

Read more on Fox News.

Leading United States medical schools are beginning to value ‘wokeism’ instead of teaching and preparing the next generation of doctors, experts warn.

Dr Stanley Goldfarb, a nephrologist at the University of Pennsylvania and often-critic of woke values in the medical field, penned an op-ed for the New York Post warning that many of the nation’s leading medical schools are screening prospective students for progressive beliefs before they do for actual medical talent.

He highlights top programs at Harvard Medical School, Columbia University, Duke University, the University of Pittsburgh and others asking applicants to answer questions about their understanding of racism, social and political issues – and how they will contribute towards progressivism in their studies.

Read more on Daily Mail.

Seventy-two percent of America’s top medical schools use racial politics to weed out applicants, according to a review conducted by medical advocacy group Do No Harm.

According to the review, 72 percent of the nation’s top 50 schools and 80 percent of the top ten ask “probing questions to elicit responses from the applicant about his or her views on diversity, equity, and inclusion topics.”

Read more on Breitbart.

Unless you’re a member of a minority protected class of persons, brace yourself to be treated unfairly by the Biden administration.

President Biden is pushing racial equity – that’s actually very different from equal treatment regardless of race. Racial equity means government can treat people unequally, to equalize outcomes. For the Biden administration, it means closing the wealth gap.

By whatever means.

Read more on Newsmax.

The best medical schools in the country are weeding out applicants who are insufficiently devoted to the leftist creed of Diversity, Equity, and Inclusion (DEI), according to a new report released by the non-profit Do No Harm.

Do No Harm, a nonprofit dedicated to “protect[ing] healthcare from a radical, divisive, and discriminatory ideology,” conducted an analysis of medical school application processes which found that these selective institutions are raising an additional barrier to entry on top of the strenuous testing and grade requirements.

“A review of the admissions process at 50 of the top-ranked medical schools found that 36 asked applicants their views on, or experience in, DEI efforts,” reads the Do No Harm report. “Many were overt in asking applicants if they agreed with certain statements about racial politics and the causes of disparate health outcomes.”

Read more on National Review.

Racial segregation is returning to health care, driven by a new generation of woke activists. The seminal study advocating this backward policy was released in June 2018 and revised three years ago this month. Titled “Does Diversity Matter For Health: Experimental Evidence from Oakland” and published in the American Economic Review, it argued that matching black patients with black physicians would save lives. The medical establishment immediately took up the banner of “racial concordance” between physicians and patients.

But the Oakland study is fatally flawed. In a new analysis, we show the shortcuts and un-scientific methods its authors used. No sound evidence supports resegregating health care, and taking this dangerous road will surely lead to worse health outcomes.

It’s important to realize how the Oakland study is reshaping health care, starting with the push for diversity in medical education and training. There aren’t enough minority physicians to make racial concordance a reality—so to get more nonwhite physicians, medical schools are ditching the MCAT for some minority students, while trainee assessments are being changed to minimize the documented differences in performance between white and so-called underrepresented minorities. These policies require lower standards, a direct threat to patient health.

Medical providers are also moving toward racial concordance. A February 2021 leak showed that UnitedHealth Group, the largest health-insurance company in America, supports matching patients with physicians based on their race. Activists are pushing hospitals and policymakers to follow suit. Yet these measures inherently undermine trust—a key part of health care—between patients and physicians with different skin colors.

The Oakland study does not justify this campaign. The authors conclude that racial concordance would lead to better health screening, leading to “a 19 percent reduction in the black-white male cardiovascular mortality gap and an 8 percent decline in the black-white male life expectancy gap.” The authors admit, however, that these are “back of the envelope calculations.” They should have designed a better study.

The first problem is that the Oakland study contains no meaningful control group. The authors recruited more than 1,300 black men from local barbershops and flea markets. The patients were randomly paired with a black or nonblack physician who attempted to persuade them to take preventative checkups. The patients generally agreed to more services with the black physicians, leading to the study’s conclusions.

Yet without a substantial control group of non-black patients, there was no way to test for many possible variables, such as the effectiveness or persuasiveness of these particular physicians unrelated to their race. The researchers belatedly tried to create a quasi-control group of 12 nonblack patients who were accidentally recruited. But this sample almost certainly differs in both observable and unobservable characteristics from the sample group, which means the two aren’t comparable.

The second problem is an abundance of unproven logical leaps. The authors believe that five one-time interventions—such as blood pressure measurement and diabetes testing—will transform individual health. Yet preventative screening is effective only if used in a patient with a high likelihood of being at risk for a particular clinical condition, something the study made no attempt to discern. These procedures also generally need to be combined with lifestyle changes and medication adherence. The researchers accounted for none of this, discounting the study’s astounding findings.

The third problem is that both the patients and physicians were unrepresentative. The patients who came to the checkups were, on average, more likely to be unemployed, less likely to have a high school diploma, and older than the general black male population. As for the physicians, only 14 were used—eight nonblack, six black. The authors use percentages to imply a far larger sample, noting in one case that 67 percent of black physicians in the study specialized in internal medicine, but that simply means four out of six. Such a small and non-random sample of physicians is not generalizable to the medical profession.

Why has such a poorly designed study seen no sustained pushback? Simple: medical journals are overrun by the same ideology that surely motivated the Oakland study itself. Academics are tacitly encouraged to submit papers that support this agenda, while those who raise questions are ignored or denied publication. The Oakland study has been uncritically referenced or relied upon by hundreds of subsequent studies and papers. Only one academic paper has raised concerns; it was subsequently retracted and its author disciplined by his medical school. The author maintains that his punishment constitutes retribution for opposing affirmative-action programs in cardiology.

On the basis of faulty research, and with no meaningful debate, health care is at risk of being resegregated. Yet more credible assessments, including a prominent 2011 study of a database of 22,000 patients, show that racial concordance between physicians and patients doesn’t produce meaningful improvements in health outcomes. Of course, patients should be free to choose their own physicians, including those who look like them. But they shouldn’t be pushed to take this path; nor should medical educators, providers, and policymakers deliberately undermine trust and lower the standards of physicians and medicals care. Segregation was horrible in the American past; it will do terrible harm now, too.

Stanley Goldfarb, a physician and former associate dean of curriculum at the University of Pennsylvania’s Perelman School of Medicine, is chairman of Do No Harm, where Alexander Raikin is a research fellow.

‘We believe this topic deserves just as much attention from learners and educators at every stage of their careers as the latest scientific breakthroughs’

The Association of American Medical Colleges recently released Diversity, Equity and Inclusion competencies for medical educators as it works to address what it calls “factors that drive racism, hate, and bias in health care.”

The DEI competencies are meant to be used to help scholars and students progress on their “DEI journeys,” the association states. But some critics contend the new curriculum advances progressive ideologies.

“The AAMC is injecting political ideology into medical education and this can only detract from the real purpose of educating physicians to care for ill patients,” Dr. Stanley Goldfarb, chairman of Do No Harm, told The College Fix in an email August 1.

Read more on The College Fix.

The group that sets the standards for medical education recently released standards that force students to study and apply ideology typically pushed by the far-left while integrating diversity, equity, and inclusion into formal curricula. 

The Association of American Medical Colleges (AAMC) published the New and Emerging Areas in Medicine series to help students benefit from “advancements in medical education over the past 20 years,” and the third report from the collection “focuses on competencies for diversity, equity, and inclusion (DEI).”

The report notes that recent medical school graduates must demonstrate “knowledge about the role of explicit and implicit bias in delivering high-quality healthy care,” “describe past and current examples of racism and oppression,” identify “systems of power, privilege and oppression and their impacts on health outcomes” including “White privilege, racism, sexism, heterosexism, ableism, religious oppression” and “articulate race as a social construct that is a cause of health and health care inequities.”

Read more on Fox News.